The Role of CXCL2 in Acute Cellular Rejection after Lung Transplantation

被引：0
|
作者：
Novysedlak, R. [1 ,2 ]
Vachtenheim, J. [1 ,2 ]
Smetanova, J. [2 ,3 ]
Slavcev, A. [4 ]
Vychytilova, K. [4 ]
Tavandzis, J. [1 ,2 ]
Balko, J. [5 ]
Lischke, R. [1 ,2 ]
Strizova, Z. [2 ,3 ]
机构：
[1] Charles Univ Prague, Prague Lung Transplant Program, Fac Med 1, Dept Surg 3, Prague, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
[3] Charles Univ Prague, Dept Immunol, Fac Med 2, Prague, Czech Republic
[4] Inst Clin & Expt Med, Dept Immunogenet, Prague, Czech Republic
[5] Charles Univ Prague, Dept Pathol & Mol Med, Fac Med 2, Prague, Czech Republic
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2023年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1260
引用
收藏
页码：S538 / S538
页数：1
相关论文
共 50 条
  • [1] Surveillance for acute cellular rejection after lung transplantation
    Greer, Mark
    Werlein, Christopher
    Jonigk, Danny
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [2] Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
    Naik, Chetan
    Moore, Cody
    Pipeling, Matthew
    D'Cunha, Jonathan
    Ruppert, Kristine
    Ensor, Christopher
    Morrell, Matthew
    TRANSPLANTATION DIRECT, 2018, 4 (05):
  • [3] Effects of Hypercapnia on Acute Cellular Rejection after Lung Transplantation in Rats
    Tan, Jing
    Liu, Yanhong
    Jiang, Tao
    Wang, Ling
    Zhao, Can
    Shen, Dongfang
    Cui, Xiaoguang
    ANESTHESIOLOGY, 2018, 128 (01) : 130 - 139
  • [4] The role for KC/CXCL1 and MIP-2/CXCL2/3 in the pathogenesis of lung transplantation ischemia reperfusion injury
    Belperio, JA
    Keane, MP
    Burdick, MD
    Xue, YY
    Li, KW
    Ardehali, A
    Ross, DJ
    Strieter, RM
    FASEB JOURNAL, 2003, 17 (05): : A1077 - A1077
  • [5] Cyclosporine C2 target levels and acute cellular rejection after lung transplantation
    Glanville, Allan R.
    Aboyoun, Christina L.
    Morton, Judith M.
    Plit, Marshall
    Malouf, Monique A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (08): : 928 - 934
  • [6] Recurrent treatment of refractory acute cellular rejection with alemtuzumab after lung transplantation
    van Haren, Eva
    van Vugt, Lukas K.
    Wijbenga, Nynke
    van der Sijs, Heleen
    Hellemons, Merel E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (11): : 1864 - 1868
  • [7] The role of innate immunity in acute allograft rejection after lung transplantation
    Palmer, SM
    Burch, LH
    Davis, RD
    Herczyk, WF
    Howell, DN
    Reinsmoen, NL
    Schwartz, DA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (06) : 628 - 632
  • [8] Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation
    Asaoka, Tadafumi
    Marubashi, Shigeru
    Kobayashi, Shogo
    Hama, Naoki
    Eguchi, Hidetoshi
    Takeda, Yutaka
    Tanemura, Masahiro
    Wada, Hiroshi
    Takemasa, Ichiro
    Takahashi, Hidenori
    Ruiz, Phillip
    Doki, Yuichiro
    Mori, Masaki
    Nagano, Hiroaki
    JOURNAL OF SURGICAL RESEARCH, 2012, 178 (02) : 1003 - 1014
  • [9] The role of surveillance transbronchial lung biopsy after lung transplantation: the potential impact of minimal acute cellular rejection or lymphocytic bronchiolitis
    Glanville, AR
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2005, 10 (03) : 211 - 215
  • [10] ROLE OF DENDRITIC CELLS AS BIOMARKERS FOR ACUTE CELLULAR REJECTION AFTER HEART TRANSPLANTATION
    Barten, Markus J.
    John, Katja
    Garbade, Jens
    Dhein, Stefan
    Mohr, Friedrich-Wilhelm
    Bittner, Hartmuth B.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 212 - 212
12345